Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Update on ConXn clinical progress

May 24, 1996

COX-2 inhibitors in clinical trials at Merck & Co.

May 24, 1996

COX-2 inhibitor selected for further study at Searle

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

SmithKline Beecham's C-DART approach to rheumatoid arthritis

May 17, 1996

Novel antiarthritics claimed by Procter & Gamble

May 17, 1996

British Biotech reveals metalloproteinase inhibitors

May 17, 1996

COX-2 inhibitors claimed by Searle

May 17, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...